KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 8.67%.

  • AbbVie's Return on Invested Capital rose 79500.0% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.67%, marking a year-over-year increase of 79500.0%. This contributed to the annual value of 0.15% for FY2024, which is 200.0% up from last year.
  • AbbVie's Return on Invested Capital amounted to 8.67% in Q3 2025, which was up 79500.0% from 3.85% recorded in Q2 2025.
  • AbbVie's Return on Invested Capital's 5-year high stood at 8.67% during Q3 2025, with a 5-year trough of 0.23% in Q4 2023.
  • Over the past 5 years, AbbVie's median Return on Invested Capital value was 0.49% (recorded in 2024), while the average stood at 1.09%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -3700bps in 2022, then skyrocketed by 79500bps in 2025.
  • Over the past 5 years, AbbVie's Return on Invested Capital (Quarter) stood at 0.3% in 2021, then rose by 1bps to 0.3% in 2022, then decreased by -24bps to 0.23% in 2023, then increased by 17bps to 0.27% in 2024, then soared by 3131bps to 8.67% in 2025.
  • Its Return on Invested Capital was 8.67% in Q3 2025, compared to 3.85% in Q2 2025 and 0.31% in Q1 2025.